Skip directly to "About CTSU" section.
IMPORTANT NOTICE
Tuesday June 30, 2015 - CTSU Holiday (July 4th) Closure:
CTSU offices will be closed Friday July 3, 2015 for the July 4th Holiday. Offices will re-open Monday, July 6, 2015 at 9:00 am ET. OPEN will be available for patient enrollment.
Wednesday July 01, 2015 - Collaboration Tab Maintenance:
Collaboration Tab within this Website will be unavailable tomorrow, Thursday, July 2nd, between 8:00 PM and 10:00 PM for certain maintenance activities. We apologize for any inconvenience this may cause you. 

Skip login prompt, directly go to "About CTSU" section.
CTSU Members
CTSU Registration Procedures
The CTSU Registration Page contains detailed information and links for Investigators and Associates to obtain access to the CTSU Members' website.
Protocol List
The Protocol List contains active NCI Clinical Trials, displays accrual information, and provides links to study abstracts and clinical sites that have the trial open.
View the list of active Rave studies showing where Safety Events are to be reported (CTEP-AERS or in Rave)
Exceptional
Responders Study
Now Active: The Exceptional Responders Study is a new initiative which studies the molecular characteristics of tumors of patients who had an exceptional response to a systemic cancer therapy. For more information click here.
ALCHEMIST
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, a set of 3 integrated, precision medicine trials testing targeted therapy in early stage lung cancer are now active. Please refer to the NCI ALCHEMIST Press Release, the NCI ALCHEMIST Question and Answer Page and the ALCHEMIST Slide Set for additional information.
Resources
Purpose of the Cancer Trials Support Unit

The Cancer Trials Support Unit (CTSU) is a service of the National Cancer Institute (NCI) designed to facilitate access to NCI-funded clinical trials for qualified clinical sites and to support the management and conduct of those clinical trials. CTSU Membership provides access to a wide range of information and support services for qualified investigators and research staff. The CTSU Registration Page provides additional details regarding member access. For those who are not CTSU Members this website provides a listing of active protocols that the CTSU supports along with links to resources for additional information on NCI-funded clinical trials.

More about the Cancer Trials Support Unit

The NCI launched the CTSU in 1999 to streamline and harmonize support services for phase three Cooperative Group cancer clinical trials funded by the NCI. Since that time the scope of the CTSU has expanded to include support of multiple NCI-funded networks and clinical trials of all phases and types including cancer treatment, prevention and control, advanced imaging and correlative science studies. The CTSU collaborates with the NCI and its funded organizations to develop and support operational processes and informatics solutions leading to cost-effective solutions that reduce administrative burden on the clinical sites.

Under guidance of the NCI, the CTSU provides centralized services to support the following goals and objectives:

  • Facilitate investigator and research staff participation in selected NCI multi-center programs and their clinical trials.
  • Increase investigator and patient awareness and enrollment to cancer clinical trials.
  • Provide standardized, integrated, and comprehensive support services to selected NCI multi-center programs.
  • Identify best practices and streamline or eliminate redundant processes and procedures.
  • Improve operational efficiency, enhance productivity and deliver products offering measurable business value to selected NCI multi-center programs.

NCI cancer research networks supported by the CTSU include:

  • NCI National Clinical Trials Network (NCTN) - is a new clinical trials research network that provides an infrastructure for NCI treatment, screening, and diagnosis trials. The new infrastructure allows investigators to begin clinical trials quicker, reach conclusions faster, and offer patients studies that incorporate precision medicine at over 3,000 clinical sites. 
  • NCI Community Oncology Research Program (NCORP) - is a community-based program that brings cancer clinical trials, as well as cancer care delivery research, to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities. 

Additional NCI and NIH services that work in conjunction with the CTSU include:

  • NCI Central Institutional Review Board (CIRB) - reduces administrative burden of local institutional review boards and investigators by partnering with local institutions to provide human subject protections by conducting IRB reviews of NCI-sponsored trials. 
  • NIH ClinicalTrials.gov - is a registry and results database that provides easy access to information on clinical studies of human participants conducted around the world.